Lorraine V Kalia

27PUBLICATIONS
105CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesKorean languagePsychosocial aspects of childbirth and perinatal mental healthGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 18, 2026
Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

|Jun 16, 2026
Deep brain stimulation in alpha-synuclein models of Parkinson's disease: Bridging the translational gap.

|Feb 10, 2026
Bridging global diversity gaps in Parkinson disease research.

Daniel Teixeira-Dos-Santos, Ai-Huey Tan, Njideka Okubadejo

|Dec 13, 2025
LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease.

Anthony E Lang, Robert A Hauser, Lorraine V Kalia

|Oct 21, 2025
Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease.

Marcus W Koch, Lorraine V Kalia, Justyna Sarna

|Aug 20, 2025
The Management of Parkinson's Disease Before, during and after Pregnancy-an MDS Scientific Issues Committee Review.

Alexander C Lehn, Jee-Young Lee, Giorgia Sciacca

Pageof 5

Frequent Collaborators

5 joint publications

Suneil K Kalia

4 joint publications

Marcus Werner Koch

3 joint publications

Mitchell L De Snoo

3 joint publications

Darren M O'Hara